Related Experiment Video
Updated: Jun 13, 2026

Studying Proteolysis of Cyclin B at the Single Cell Level in Whole Cell Populations
Published on: September 17, 2012
C/EBP{delta} targets cyclin D1 for proteasome-mediated degradation via induction of CDC27/APC3 expression
Snehalata A Pawar1, Tapasree Roy Sarkar, Kuppusamy Balamurugan
1Center for Cancer Research, National Cancer Institute, Frederick, MD 21702-1201, USA.
Abstract:
The transcription factor CCAAT/enhancer binding protein delta (C/EBPdelta, CEBPD, NFIL-6beta) has tumor suppressor function; however, the molecular mechanism(s) by which C/EBPdelta exerts its effect are largely unknown. Here, we report that C/EBPdelta induces expression of the Cdc27 (APC3) subunit of the anaphase promoting complex/cyclosome (APC/C), which results in the polyubiquitination and degradation of the prooncogenic cell cycle regulator cyclin D1, and also down-regulates cyclin B1, Skp2, and Plk-1. In C/EBPdelta knockout mouse embryo fibroblasts (MEF) Cdc27 levels were reduced, whereas cyclin D1 levels were increased even in the presence of activated GSK-3beta. Silencing of C/EBPdelta, Cdc27, or the APC/C coactivator Cdh1 (FZR1) in MCF-10A breast epithelial cells increased cyclin D1 protein expression. Like C/EBPdelta, and in contrast to cyclin D1, Cdc27 was down-regulated in several breast cancer cell lines, suggesting that Cdc27 itself may be a tumor suppressor. Cyclin D1 is a known substrate of polyubiquitination complex SKP1/CUL1/F-box (SCF), and our studies show that Cdc27 directs cyclin D1 to alternative degradation by APC/C. These findings shed light on the role and regulation of APC/C, which is critical for most cellular processes.
Insights
CCAAT/enhancer binding protein delta (C/EBPdelta) promotes tumor suppression by increasing Cdc27, which degrades cyclin D1. This reveals a new mechanism for C/EBPdelta
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- CCAAT/enhancer binding protein delta (C/EBPdelta) is a transcription factor with known tumor suppressor functions.
- The precise molecular mechanisms underlying C/EBPdelta's tumor suppressor activity remain largely unelucidated.
- Understanding these mechanisms is crucial for developing targeted cancer therapies.
Purpose of the Study:
- To elucidate the molecular mechanisms by which C/EBPdelta exerts its tumor suppressor function.
- To investigate the role of C/EBPdelta in regulating cell cycle proteins and the anaphase promoting complex/cyclosome (APC/C).
- To determine if Cdc27, a subunit of APC/C, has potential tumor suppressor activity.
Main Methods:
- Utilized C/EBPdelta knockout mouse embryo fibroblasts (MEFs) to assess protein level changes.
- Employed gene silencing techniques (siRNA) in MCF-10A breast epithelial cells to study the effects of C/EBPdelta, Cdc27, and Cdh1.
- Analyzed protein expression levels of key cell cycle regulators including cyclin D1, cyclin B1, Skp2, and Plk-1.
- Investigated the degradation pathways of cyclin D1, comparing SCF and APC/C mediated ubiquitination.
Main Results:
- C/EBPdelta induces the expression of Cdc27 (APC3), a subunit of the APC/C complex.
- Induced Cdc27 leads to polyubiquitination and degradation of the pro-oncogenic cyclin D1.
- C/EBPdelta also down-regulates cyclin B1, Skp2, and Plk-1.
- Reduced Cdc27 levels were observed in C/EBPdelta knockout MEFs, correlating with increased cyclin D1.
- Silencing C/EBPdelta, Cdc27, or Cdh1 in breast cells increased cyclin D1.
- Cdc27 expression is downregulated in several breast cancer cell lines, suggesting its role as a tumor suppressor.
- Cdc27 mediates an alternative degradation pathway for cyclin D1 via APC/C.
Conclusions:
- C/EBPdelta functions as a tumor suppressor by upregulating Cdc27, which targets cyclin D1 for degradation.
- Cdc27 itself may act as a tumor suppressor due to its downregulation in breast cancer cells.
- These findings reveal a novel regulatory role for APC/C in controlling cyclin D1 stability and highlight C/EBPdelta's mechanism in cell cycle regulation.
More Related Videos
12:26Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
Related Concept Videos
Anaphase Promoting Complex
Anaphase Promoting Complex
Inhibition of Cdk Activity
Inhibition of CDK Activity
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
Positive Regulator Molecules